These tumors are less likely to spread to surrounding tissues than higher-grade tumors, so they often have better outcomes. In the past, pediatric gliomas were classified into low-grade and high-grade ...

Pediatric low-grade gliomas (pLGGs) are slow-growing brain or spinal tumors in kids that rarely spread. They're often treatable with surgery or medicine. Symptoms like headaches, vision changes, ...

Every parent wants their child to do well at school, both academically and socially. But pediatric low-grade glioma (pLGG) can sometimes stand in the way of those goals. The side effects of treatment ...

Pediatric gliomas are also known as childhood gliomas. They’re a type of tumor that can develop in a child’s central nervous system (CNS), including their brain or spinal cord. Gliomas are tumors that ...

Gomekli showed an 87% overall response rate in pediatric low-grade glioma with MAPK pathway activation, with a recommended dose of 3 mg/m2 twice daily. Common adverse effects included weight gain, ...

At the International Symposium on Pediatric Neuro-Oncology (ISPNO), researchers presented findings from two trials aimed at overcoming resistance to standard BRAF/MEK-targeted therapies in patients ...

The conditional marketing authorization for tovorafenib in pediatric patients with low-grade glioma harboring a BRAF alteration is based on data from the FIREFLY-1 trial. According to the news release ...

Pediatric low‑grade gliomas (pLGGs) have distinct biology and treatment strategies compared to adult gliomas. These Chinese consensus guidelines, developed by a multidisciplinary panel, integrate ...

New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda® (tovorafenib) ...